DIGITAL EDITION

ARCHIVES

Category: Topics

Prescription Psychostimulant Abuse

by Randy A. Sansone, MD; and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of

Blood Brain Barrier: The Role of Pyridoxine

by Atmaram Yarlagadda, MD; and Anita H. Clayton, MD Dr. Yarlagadda is from McDonald Army Health Center, Fort Eustis, Virginia, and from Clinical Associates of Tidewater, Newport News, Virginia; and

A Multidimensional Approach to Medication Selection in the Treatment of Children and Adolescents with ADHD

by Atilla Turgay, MD, FRCPC Dr. Atilla Turgay is from the University of Toronto and the Scarborough Hospital.

Alzheimer’s Therapies

by Elisa F. Cascade; Amir H. Kalali, MD; and Edmund Howe, MD, JD Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is

The FDA and the Drug Approval Process

by William D. Schwieterman, MD, PhD; and Steven D. Targum, MD Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells

Lisdexamfetamine Dimesylate: The First Prodrug Stimulant

by David W. Goodman, MD Dr. Goodman is from the Adult Attention Deficit Disorder Center of Maryland, Johns Hopkins at Green Spring Station, Lutherville, Maryland; and Assistant Professor, Johns Hopkins

An Atomoxetine Tutorial

by David Feifel, MD, PhD Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San

Understanding and Encouraging the Overweight Patient

by Alicia R. Ruelaz, MD Dr. Ruelaz is from Cedars-Sinai Medical Center, Department of Psychiatry, and Associate Director, Consultation-Liaison Division Faculty Psychiatrist, Cedars-Sinai Center for Weight Loss, Los Angeles, California.

Initial Screening of Patients for Alzheimer’s Disease and Minimal Cognitive Impairment

by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, and Director, Programs in Medical Ethics, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Blood Brain Barrier: The Role of GAD Antibodies in Psychiatry

by Atmaram Yarlagadda, MD; Badalin Helvink, MD; Caroline Chou, MD; and Anita H. Clayton, MD Dr. Yarlagadda is from McDonald Army Health Center, Fort Eustis, Virginia; Dr. Helvink was with